A client with end-stage renal disease (ESRD) is receiving erythropoietin-stimulating agents (ESAs) as part of the dialysis treatment. Which of the following statements by the client indicates an understanding of the medication's purpose?
"ESAs help prevent infection during dialysis."
"ESAs stimulate red blood cell production."
"ESAs reduce the risk of blood clot formation."
"ESAs enhance kidney function and filtration."
The Correct Answer is B
A) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) are not used to prevent infections during dialysis. They are used to address anemia by stimulating red blood cell production.
B) This statement is accurate. Erythropoietin-stimulating agents (ESAs) stimulate the bone marrow to produce more red blood cells, addressing anemia commonly associated with chronic kidney disease and dialysis.
C) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) do not reduce the risk of blood clot formation. They are specific to stimulating the production of red blood cells.
D) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) do not enhance kidney function and filtration. They target the production of red blood cells to address anemia associated with ESRD and dialysis.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A) This statement is incorrect. Hypermagnesemia (elevated magnesium levels) can be a concern in ESRD, but it is not a primary indication for initiating dialysis. Magnesium levels can be managed through dietary restrictions and medications without the need for dialysis.
B) This statement is incorrect. Hyperphosphatemia (elevated phosphorus levels) is a common issue in ESRD, but it is not a primary indication for initiating dialysis. Clients with ESRD may receive phosphate binders to control phosphorus levels without necessarily needing immediate dialysis.
C) This statement is incorrect. Hyperkalemia (elevated potassium levels) is a concern in ESRD, but it is not the primary indication described in the scenario. While hyperkalemia may occur with fluid overload, the primary concern in this case is the hypervolemia and its associated symptoms.
D) Hypervolemia (severe fluid overload) is a critical indication for initiating dialysis in clients with end-stage renal disease. Dialysis helps remove excess fluid from the body and can relieve symptoms such as pulmonary edema and hypertension.
Correct Answer is B
Explanation
A. Incorrect. Warming the dialysate fluid to body temperature before instilling it into the peritoneal cavity is a standard procedure in continuous ambulatory peritoneal dialysis (CAPD. .
B. Correct. Performing the exchanges in a clean, dry environment free from pets is crucial to prevent contamination and reduce the risk of infection during CAPD.
C. Incorrect. Using tap water to cleanse the catheter insertion site before the exchange is not recommended. The catheter exit site should be cleaned with an appropriate antiseptic solution as instructed by the healthcare provider.
D. Incorrect. While daily dressing changes are important, using sterile technique for catheter dressing changes may not be necessary, as the dressing does not directly contact the peritoneal cavity during CAPD exchanges.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
